LentiGlobin for Sickle Cell Disease | NEJM

Journal Club 5: LentiGlobin for Sickle Cell Disease​Подробнее

Can CRISPR cure Sickle-cell Disease?Подробнее

Triumphs in Sickle Cell CRISPR #sicklecellanemiaПодробнее

Glutamine to Treat Sickle Cell DiseaseПодробнее

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia CTX001 on NEJMПодробнее

Sickle Cell Disease and Gene Therapy — Patient and Physician Perspectives | NEJMПодробнее

Sickle Cell Anemia NEJMПодробнее

Hydroxyurea for Sickle Cell AnemiaПодробнее

Adjuvant Pembrolizumab and Survival in Renal-Cell Carcinoma | NEJMПодробнее

Childhood CV Risk Factors and Adult CV Events | NEJMПодробнее

NEJM Interview: Dr. Keith Wailoo on the medical and social context that has made progress in trea...Подробнее

Dr. Caterina Minniti: Using L-glutamine to Treat Sickle Cell DiseaseПодробнее

Za'Mya Braves Sickle Cell DiseaseПодробнее

Sickle Cell Gene Therapy TrialПодробнее

Gene therapy is the future of sickle cell diseaseПодробнее

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell DiseaseПодробнее

CRISPR for Sickle Cell Disease: The Real StoryПодробнее